EGFR and head and neck squamous cell carcinoma: We have developed a model of acquired resistance to EGFR TKIs based on the human HNSCC cell line CAL 27, and shown that a resistant derivative (CALR) exhibits a distinct protein expression signature compared with its sensitive counterpart (CALS) (Box et al, 2013a).